MediWound hosts virtual expert event on EscharEx Phase III study
MDWD•MediWound will host a virtual expert event on December 2 to discuss EscharEx clinical evidence, its Phase III VALUE study and an estimated $1.05 billion in U.S. annual peak sales potential.




